go back

Lisocabtagene Maraleucel (Breyanzi)

Massachusetts rates for HCPCS C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $7,079 · 10th–90th $1,995$426,5800%20%10th90th$7,079Professionalmedian $645,654 · 10th–90th $645,654$645,6540%50%100%$645,654$100.0$500.0$2.0K$10.0K$50.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
AllWays Health Partners
Setting
Facility
Modifier
Global
Typical Low
$426,579.52
Median
$426,579.52
Typical High
$426,579.52
AllWays Health Partners
Setting
Professional
Modifier
Global
Typical Low
$645,654.23
Median
$645,654.23
Typical High
$645,654.23
Fallon Health
Setting
Facility
Modifier
Global
Typical Low
$83.18
Median
$5,888.44
Typical High
$9,772.37
Mass General Brigham
Setting
Facility
Modifier
Global
Typical Low
$426,579.52
Median
$426,579.52
Typical High
$426,579.52
Mass General Brigham
Setting
Professional
Modifier
Global
Typical Low
$645,654.23
Median
$645,654.23
Typical High
$645,654.23